Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Context-based learning for Inhibition of alternative conceptions: the next step forward in science education.

NPJ science of learning

Renouard A, Mazabraud Y.
PMID: 30631471
NPJ Sci Learn. 2018 Jun 22;3:10. doi: 10.1038/s41539-018-0026-9. eCollection 2018.

The scientific literacy level of the whole population has long been focusing the researchers' attention because of its direct impact on many aspects of our lives. As a matter of fact, studies in cognition have both been inspired by...

Cite
Renouard A, Mazabraud Y. Context-based learning for Inhibition of alternative conceptions: the next step forward in science education. NPJ Sci Learn. 2018;3:10doi: 10.1038/s41539-018-0026-9.
Renouard, A., & Mazabraud, Y. (2018). Context-based learning for Inhibition of alternative conceptions: the next step forward in science education. NPJ science of learning, 310. https://doi.org/10.1038/s41539-018-0026-9
Renouard, Alexandra, and Mazabraud, Yves. "Context-based learning for Inhibition of alternative conceptions: the next step forward in science education." NPJ science of learning vol. 3 (2018): 10. doi: https://doi.org/10.1038/s41539-018-0026-9
Renouard A, Mazabraud Y. Context-based learning for Inhibition of alternative conceptions: the next step forward in science education. NPJ Sci Learn. 2018 Jun 22;3:10. doi: 10.1038/s41539-018-0026-9. eCollection 2018. PMID: 30631471; PMCID: PMC6220291.
Copy Download .nbib Format: NLM
[Anatomo-pathologic examination: method of Dockerty].

Revue du rhumatisme et des maladies osteo-articulaires

MAZABRAUD A, BENASSY J.
PMID: 13518966
Rev Rhum Mal Osteoartic. 1957 Sep-Oct;24(9):669-70.

No abstract available.

Cite
MAZABRAUD A, BENASSY J. L'examen anatomo-pathologique immediat: la methode de Dockerty. [Anatomo-pathologic examination: method of Dockerty]. Rev Rhum Mal Osteoartic. 1957;24(9):669-70
MAZABRAUD, A., & BENASSY, J. (1957). L'examen anatomo-pathologique immediat: la methode de Dockerty. [Anatomo-pathologic examination: method of Dockerty]. Revue du rhumatisme et des maladies osteo-articulaires, 24(9), 669-70.
MAZABRAUD, A, and BENASSY, J. "L'examen anatomo-pathologique immediat: la methode de Dockerty." [Anatomo-pathologic examination: method of Dockerty]. Revue du rhumatisme et des maladies osteo-articulaires vol. 24,9 (1957): 669-70.
MAZABRAUD A, BENASSY J. L'examen anatomo-pathologique immediat: la methode de Dockerty. [Anatomo-pathologic examination: method of Dockerty]. Rev Rhum Mal Osteoartic. 1957 Sep-Oct;24(9):669-70. French. PMID: 13518966.
Copy Download .nbib Format: NLM
Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients.

Journal of global antimicrobial resistance

Premachandra A, Mazeraud A, Schimpf C, Tortuyaux R, Legouy C, Daniel M, Sauvageon X, Benmostefa A, Sermet A, Sharshar T, Wolff M.
PMID: 34715350
J Glob Antimicrob Resist. 2021 Oct 26;27:247-249. doi: 10.1016/j.jgar.2021.10.013. Epub 2021 Oct 26.

No abstract available.

Cite
Premachandra A, Mazeraud A, Schimpf C, et al. Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. J Glob Antimicrob Resist. 2021;27:247-249doi: 10.1016/j.jgar.2021.10.013.
Premachandra, A., Mazeraud, A., Schimpf, C., Tortuyaux, R., Legouy, C., Daniel, M., Sauvageon, X., Benmostefa, A., Sermet, A., Sharshar, T., & Wolff, M. (2021). Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. Journal of global antimicrobial resistance, 27247-249. https://doi.org/10.1016/j.jgar.2021.10.013
Premachandra, A, et al. "Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients." Journal of global antimicrobial resistance vol. 27 (2021): 247-249. doi: https://doi.org/10.1016/j.jgar.2021.10.013
Premachandra A, Mazeraud A, Schimpf C, Tortuyaux R, Legouy C, Daniel M, Sauvageon X, Benmostefa A, Sermet A, Sharshar T, Wolff M. Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. J Glob Antimicrob Resist. 2021 Oct 26;27:247-249. doi: 10.1016/j.jgar.2021.10.013. Epub 2021 Oct 26. PMID: 34715350.
Copy Download .nbib Format: NLM
Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients.

Journal of global antimicrobial resistance

Premachandra A, Mazeraud A, Schimpf C, Tortuyaux R, Legouy C, Daniel M, Sauvageon X, Benmostefa A, Sermet A, Sharshar T, Wolff M.
PMID: 34715350
J Glob Antimicrob Resist. 2021 Dec;27:247-249. doi: 10.1016/j.jgar.2021.10.013. Epub 2021 Oct 26.

No abstract available.

Cite
Premachandra A, Mazeraud A, Schimpf C, et al. Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. J Glob Antimicrob Resist. 2021;27:247-249doi: 10.1016/j.jgar.2021.10.013.
Premachandra, A., Mazeraud, A., Schimpf, C., Tortuyaux, R., Legouy, C., Daniel, M., Sauvageon, X., Benmostefa, A., Sermet, A., Sharshar, T., & Wolff, M. (2021). Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. Journal of global antimicrobial resistance, 27247-249. https://doi.org/10.1016/j.jgar.2021.10.013
Premachandra, A, et al. "Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients." Journal of global antimicrobial resistance vol. 27 (2021): 247-249. doi: https://doi.org/10.1016/j.jgar.2021.10.013
Premachandra A, Mazeraud A, Schimpf C, Tortuyaux R, Legouy C, Daniel M, Sauvageon X, Benmostefa A, Sermet A, Sharshar T, Wolff M. Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. J Glob Antimicrob Resist. 2021 Dec;27:247-249. doi: 10.1016/j.jgar.2021.10.013. Epub 2021 Oct 26. PMID: 34715350.
Copy Download .nbib Format: NLM
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.

The Lancet. Respiratory medicine

Mazeraud A, Jamme M, Mancusi RL, Latroche C, Megarbane B, Siami S, Zarka J, Moneger G, Santoli F, Argaud L, Chillet P, Muller G, Bruel C, Asfar P, Beloncle F, Reignier J, Vinsonneau C, Schimpf C, Amour J, Goulenok C, Lemaitre C, Rohaut B, Mateu P, De Rudnicki S, Mourvillier B, Declercq PL, Schwebel C, Stoclin A, Garnier M, Madeux B, Gaudry S, Bailly K, Lamer C, Aegerter P, Rieu C, Sylla K, Lucas B, Sharshar T.
PMID: 34774185
Lancet Respir Med. 2021 Nov 11; doi: 10.1016/S2213-2600(21)00440-9. Epub 2021 Nov 11.

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a major complication of COVID-19 and is associated with high mortality and morbidity. We aimed to assess whether intravenous immunoglobulins (IVIG) could improve outcomes by reducing inflammation-mediated lung injury.METHODS: In this multicentre,...

Cite
Mazeraud A, Jamme M, Mancusi RL, et al. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;doi: 10.1016/S2213-2600(21)00440-9.
Mazeraud, A., Jamme, M., Mancusi, R. L., Latroche, C., Megarbane, B., Siami, S., Zarka, J., Moneger, G., Santoli, F., Argaud, L., Chillet, P., Muller, G., Bruel, C., Asfar, P., Beloncle, F., Reignier, J., Vinsonneau, C., Schimpf, C., Amour, J., Goulenok, C., Lemaitre, C., Rohaut, B., Mateu, P., De Rudnicki, S., Mourvillier, B., Declercq, P. L., Schwebel, C., Stoclin, A., Garnier, M., Madeux, B., Gaudry, S., Bailly, K., Lamer, C., Aegerter, P., Rieu, C., Sylla, K., Lucas, B., & Sharshar, T. (2021). Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. The Lancet. Respiratory medicine, . https://doi.org/10.1016/S2213-2600(21)00440-9
Mazeraud, Aurélien, et al. "Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial." The Lancet. Respiratory medicine vol. (2021). doi: https://doi.org/10.1016/S2213-2600(21)00440-9
Mazeraud A, Jamme M, Mancusi RL, Latroche C, Megarbane B, Siami S, Zarka J, Moneger G, Santoli F, Argaud L, Chillet P, Muller G, Bruel C, Asfar P, Beloncle F, Reignier J, Vinsonneau C, Schimpf C, Amour J, Goulenok C, Lemaitre C, Rohaut B, Mateu P, De Rudnicki S, Mourvillier B, Declercq PL, Schwebel C, Stoclin A, Garnier M, Madeux B, Gaudry S, Bailly K, Lamer C, Aegerter P, Rieu C, Sylla K, Lucas B, Sharshar T. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 Nov 11; doi: 10.1016/S2213-2600(21)00440-9. Epub 2021 Nov 11. PMID: 34774185; PMCID: PMC8585489.
Copy Download .nbib Format: NLM
[Immediate anatomopathological examination; Dockerty method].

La Presse medicale

MAZABRAUD A, BENASSY J.
PMID: 13623743
Presse Med. 1958 Dec 25;66(91):2071-2.

No abstract available.

Cite
MAZABRAUD A, BENASSY J. L'examen anatomo-pathologique immédiat. la méthode de Dockerty. [Immediate anatomopathological examination; Dockerty method]. Presse Med. 1958;66(91):2071-2
MAZABRAUD, A., & BENASSY, J. (1958). L'examen anatomo-pathologique immédiat. la méthode de Dockerty. [Immediate anatomopathological examination; Dockerty method]. La Presse medicale, 66(91), 2071-2.
MAZABRAUD, A, and BENASSY, J. "L'examen anatomo-pathologique immédiat. la méthode de Dockerty." [Immediate anatomopathological examination; Dockerty method]. La Presse medicale vol. 66,91 (1958): 2071-2.
MAZABRAUD A, BENASSY J. L'examen anatomo-pathologique immédiat. la méthode de Dockerty. [Immediate anatomopathological examination; Dockerty method]. Presse Med. 1958 Dec 25;66(91):2071-2. French. PMID: 13623743.
Copy Download .nbib Format: NLM
The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels.

Frontiers in cellular neuroscience

Boulay AC, Saubaméa B, Cisternino S, Mignon V, Mazeraud A, Jourdren L, Blugeon C, Cohen-Salmon M.
PMID: 25698924
Front Cell Neurosci. 2015 Feb 02;9:9. doi: 10.3389/fncel.2015.00009. eCollection 2015.

Astrocytes, the most prominent glial cell type in the brain, send specialized processes called endfeet, around blood vessels and express a large molecular repertoire regulating the cerebrovascular system physiology. One of the most striking properties of astrocyte endfeet is...

Cite
Boulay AC, Saubaméa B, Cisternino S, et al. The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels. Front Cell Neurosci. 2015;9:9doi: 10.3389/fncel.2015.00009.
Boulay, A. C., Saubaméa, B., Cisternino, S., Mignon, V., Mazeraud, A., Jourdren, L., Blugeon, C., & Cohen-Salmon, M. (2015). The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels. Frontiers in cellular neuroscience, 99. https://doi.org/10.3389/fncel.2015.00009
Boulay, Anne-Cécile, et al. "The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels." Frontiers in cellular neuroscience vol. 9 (2015): 9. doi: https://doi.org/10.3389/fncel.2015.00009
Boulay AC, Saubaméa B, Cisternino S, Mignon V, Mazeraud A, Jourdren L, Blugeon C, Cohen-Salmon M. The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels. Front Cell Neurosci. 2015 Feb 02;9:9. doi: 10.3389/fncel.2015.00009. eCollection 2015. PMID: 25698924; PMCID: PMC4313713.
Copy Download .nbib Format: NLM
Molecular Characterization of Airport Malaria.

Journal of travel medicine

Basco LK, de Pécoulas PE, Le Bras J, Mazabraud A, Wilson CM.
PMID: 9815451
J Travel Med. 1996 Sep 01;3(3):179-181. doi: 10.1111/j.1708-8305.1996.tb00737.x.

No abstract available.

Cite
Basco LK, de Pécoulas PE, Le Bras J, et al. Molecular Characterization of Airport Malaria. J Travel Med. 1996;3(3):179-181doi: 10.1111/j.1708-8305.1996.tb00737.x.
Basco, L. K., de Pécoulas PE, Le Bras J, Mazabraud, A., & Wilson, C. M. (1996). Molecular Characterization of Airport Malaria. Journal of travel medicine, 3(3), 179-181. https://doi.org/10.1111/j.1708-8305.1996.tb00737.x
Basco, et al. "Molecular Characterization of Airport Malaria." Journal of travel medicine vol. 3,3 (1996): 179-181. doi: https://doi.org/10.1111/j.1708-8305.1996.tb00737.x
Basco LK, de Pécoulas PE, Le Bras J, Mazabraud A, Wilson CM. Molecular Characterization of Airport Malaria. J Travel Med. 1996 Sep 01;3(3):179-181. doi: 10.1111/j.1708-8305.1996.tb00737.x. PMID: 9815451.
Copy Download .nbib Format: NLM
Septic-Associated Encephalopathy: a Comprehensive Review.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T.
PMID: 32378026
Neurotherapeutics. 2020 Apr;17(2):392-403. doi: 10.1007/s13311-020-00862-1.

Septic-associated encephalopathy (SAE) is a key manifestation of sepsis, ranging from delirium to coma and occurring in up to 70% of patients admitted to the ICU. SAE is associated with higher ICU and hospital mortality, and also with poorer...

Cite
Mazeraud A, Righy C, Bouchereau E, et al. Septic-Associated Encephalopathy: a Comprehensive Review. Neurotherapeutics. 2020;17(2):392-403doi: 10.1007/s13311-020-00862-1.
Mazeraud, A., Righy, C., Bouchereau, E., Benghanem, S., Bozza, F. A., & Sharshar, T. (2020). Septic-Associated Encephalopathy: a Comprehensive Review. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 17(2), 392-403. https://doi.org/10.1007/s13311-020-00862-1
Mazeraud, Aurélien, et al. "Septic-Associated Encephalopathy: a Comprehensive Review." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics vol. 17,2 (2020): 392-403. doi: https://doi.org/10.1007/s13311-020-00862-1
Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T. Septic-Associated Encephalopathy: a Comprehensive Review. Neurotherapeutics. 2020 Apr;17(2):392-403. doi: 10.1007/s13311-020-00862-1. PMID: 32378026; PMCID: PMC7283452.
Copy Download .nbib Format: NLM
Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients.

Journal of global antimicrobial resistance

Premachandra A, Mazeraud A, Schimpf C, Tortuyaux R, Legouy C, Daniel M, Sauvageon X, Benmostefa A, Sermet A, Sharshar T, Wolff M.
PMID: 34715350
J Glob Antimicrob Resist. 2021 Dec;27:247-249. doi: 10.1016/j.jgar.2021.10.013. Epub 2021 Oct 26.

No abstract available.

Cite
Premachandra A, Mazeraud A, Schimpf C, et al. Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. J Glob Antimicrob Resist. 2021;27:247-249doi: 10.1016/j.jgar.2021.10.013.
Premachandra, A., Mazeraud, A., Schimpf, C., Tortuyaux, R., Legouy, C., Daniel, M., Sauvageon, X., Benmostefa, A., Sermet, A., Sharshar, T., & Wolff, M. (2021). Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. Journal of global antimicrobial resistance, 27247-249. https://doi.org/10.1016/j.jgar.2021.10.013
Premachandra, A, et al. "Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients." Journal of global antimicrobial resistance vol. 27 (2021): 247-249. doi: https://doi.org/10.1016/j.jgar.2021.10.013
Premachandra A, Mazeraud A, Schimpf C, Tortuyaux R, Legouy C, Daniel M, Sauvageon X, Benmostefa A, Sermet A, Sharshar T, Wolff M. Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients. J Glob Antimicrob Resist. 2021 Dec;27:247-249. doi: 10.1016/j.jgar.2021.10.013. Epub 2021 Oct 26. PMID: 34715350.
Copy Download .nbib Format: NLM
What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Dal-Pizzol F, de Medeiros GF, Michels M, Mazeraud A, Bozza FA, Ritter C, Sharshar T.
PMID: 33410107
Neurotherapeutics. 2021 Apr;18(2):1393-1413. doi: 10.1007/s13311-020-00981-9. Epub 2021 Jan 06.

Lower sepsis mortality rates imply that more patients are discharged from the hospital, but sepsis survivors often experience sequelae, such as functional disability, cognitive impairment, and psychiatric morbidity. Nevertheless, the mechanisms underlying these long-term disabilities are not fully understood....

Cite
Dal-Pizzol F, de Medeiros GF, Michels M, et al. What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review. Neurotherapeutics. 2021;18(2):1393-1413doi: 10.1007/s13311-020-00981-9.
Dal-Pizzol, F., de Medeiros, G. F., Michels, M., Mazeraud, A., Bozza, F. A., Ritter, C., & Sharshar, T. (2021). What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 18(2), 1393-1413. https://doi.org/10.1007/s13311-020-00981-9
Dal-Pizzol, Felipe, et al. "What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics vol. 18,2 (2021): 1393-1413. doi: https://doi.org/10.1007/s13311-020-00981-9
Dal-Pizzol F, de Medeiros GF, Michels M, Mazeraud A, Bozza FA, Ritter C, Sharshar T. What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review. Neurotherapeutics. 2021 Apr;18(2):1393-1413. doi: 10.1007/s13311-020-00981-9. Epub 2021 Jan 06. PMID: 33410107; PMCID: PMC8423874.
Copy Download .nbib Format: NLM
Vasopressor Therapy and the Brain: Dark Side of the Moon.

Frontiers in medicine

Heming N, Mazeraud A, Azabou E, Moine P, Annane D.
PMID: 31998736
Front Med (Lausanne). 2020 Jan 10;6:317. doi: 10.3389/fmed.2019.00317. eCollection 2019.

Sepsis, a leading cause of morbidity and mortality, is caused by a deregulated host response to pathogens, and subsequent life-threatening organ dysfunctions. All major systems, including the cardiovascular, respiratory, renal, hepatic, hematological, and the neurological system may be affected...

Cite
Heming N, Mazeraud A, Azabou E, et al. Vasopressor Therapy and the Brain: Dark Side of the Moon. Front Med (Lausanne). 2020;6:317doi: 10.3389/fmed.2019.00317.
Heming, N., Mazeraud, A., Azabou, E., Moine, P., & Annane, D. (2019). Vasopressor Therapy and the Brain: Dark Side of the Moon. Frontiers in medicine, 6317. https://doi.org/10.3389/fmed.2019.00317
Heming, Nicholas, et al. "Vasopressor Therapy and the Brain: Dark Side of the Moon." Frontiers in medicine vol. 6 (2019): 317. doi: https://doi.org/10.3389/fmed.2019.00317
Heming N, Mazeraud A, Azabou E, Moine P, Annane D. Vasopressor Therapy and the Brain: Dark Side of the Moon. Front Med (Lausanne). 2020 Jan 10;6:317. doi: 10.3389/fmed.2019.00317. eCollection 2019. PMID: 31998736; PMCID: PMC6966606.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries